Livzon Pharma Publishes Revised Proxy Form for 2025 AGM; Original Version Void

Bulletin Express04-24

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a revised proxy form for the 2025 Annual General Meeting scheduled on 29 May 2026. The update addresses typographical and formatting adjustments only, with no substantive changes to the original content.

The original proxy form dated 23 April 2026 is now void. Shareholders who previously submitted that version must complete and lodge the newly released form. Submission methods, deadlines, and all other related requirements remain unchanged; detailed instructions are provided in the revised document.

The updated proxy form is available on the websites of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the company (www.livzon.com.cn). Livzon Pharma has apologized for any inconvenience caused by the formatting adjustments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159111324?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-24 21:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159111324","market":"us","top_or_hot":-1,"title":"Livzon Pharma Publishes Revised Proxy Form for 2025 AGM; Original Version Void","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a revised proxy form for the 2025 Annual General Meeting scheduled on 29 May 2026. The update addresses typographical and formatting adjustments only, with no substantive changes to the original content.</p>\n<p>The original proxy form dated 23 April 2026 is now void. Shareholders who previously submitted that version must complete and lodge the newly released form. Submission methods, deadlines, and all other related requirements remain unchanged; detailed instructions are provided in the revised document.</p>\n<p>The updated proxy form is available on the websites of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the company (www.livzon.com.cn). Livzon Pharma has apologized for any inconvenience caused by the formatting adjustments.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Publishes Revised Proxy Form for 2025 AGM; Original Version Void</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Publishes Revised Proxy Form for 2025 AGM; Original Version Void\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-24 21:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a revised proxy form for the 2025 Annual General Meeting scheduled on 29 May 2026. The update addresses typographical and formatting adjustments only, with no substantive changes to the original content.</p>\n<p>The original proxy form dated 23 April 2026 is now void. Shareholders who previously submitted that version must complete and lodge the newly released form. Submission methods, deadlines, and all other related requirements remain unchanged; detailed instructions are provided in the revised document.</p>\n<p>The updated proxy form is available on the websites of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the company (www.livzon.com.cn). Livzon Pharma has apologized for any inconvenience caused by the formatting adjustments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1159111324","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159111324","pubTimestamp":1777037109,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a revised proxy form for the 2025 Annual General Meeting scheduled on 29 May 2026. The update addresses typographical and formatting...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药发布2025年年度股东大会修订后的委托书；原始版本无效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a revised proxy form for the 2025 Annual General Meeting scheduled on 29 May 2026. The update addresses typographical and formatting adjustments only, with no substantive changes to the original content.\nThe original proxy form dated 23 April 2026 is now void. Shareholders who previously submitted that version must complete and lodge the newly released form. Submission methods, deadlines, and all other related requirements remain unchanged; detailed instructions are provided in the revised document.\nThe updated proxy form is available on the websites of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk) and the company (www.livzon.com.cn). Livzon Pharma has apologized for any inconvenience caused by the formatting adjustments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159111324","isCrawlerRequest":true}